A detailed history of Dhjj Financial Advisors, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dhjj Financial Advisors, Ltd. holds 819 shares of BMY stock, worth $38,337. This represents 0.01% of its overall portfolio holdings.

Number of Shares
819
Previous 815 0.49%
Holding current value
$38,337
Previous $36,000 5.56%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 22, 2026

BUY
$42.6 - $49.08 $170 - $196
4 Added 0.49%
819 $38,000
Q3 2025

Oct 20, 2025

BUY
$43.31 - $48.98 $1,472 - $1,665
34 Added 4.35%
815 $36,000
Q2 2025

Jul 21, 2025

BUY
$44.12 - $59.6 $11,780 - $15,913
267 Added 51.95%
781 $36,000
Q4 2024

Jan 29, 2025

SELL
$51.92 - $59.94 $10,384 - $11,988
-200 Reduced 28.01%
514 $29,000
Q2 2024

Jul 11, 2024

SELL
$40.25 - $52.99 $2,012 - $2,649
-50 Reduced 6.54%
714 $29,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $44,227 - $49,453
764 New
764 $44,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dhjj Financial Advisors, Ltd. Portfolio

Follow Dhjj Financial Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dhjj Financial Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Dhjj Financial Advisors, Ltd. with notifications on news.